- The Wall Street Journal•16 hours ago
An executive who guided venture-backed InnoPharma to a $360 million merger with Pfizer in 2014 has led the fundraising.
- Bloomberg Video•18 hours ago
July 27 -- Dan Deming, KKM Financial's managing director, discusses the performance of stocks and his options strategy for Pfizer with Bloomberg's Julie Hyman on "Bloomberg Markets."
|Bid||36.77 x 1100|
|Ask||36.78 x 6000|
|52wk Range||28.25 - 37.19|
|Day's Range||36.70 - 36.91|
|Avg Vol (3m)||24,873,339|
As of 10:11 AM EDT. NYSE Real Time Price. Market open.